Dr. Dinesh Khanna

DOI Web Site

説明

<p>Dinesh Khanna, MD, MSc, is Professor of Medicine and Director, University of Michigan Scleroderma Program. He holds the Frederick G.L. Huetwell Professorship in Rheumatology. Dr. Khanna has published over 550 peer-reviewed articles and book chapters. He is the Principal Investigator on the National Institutes of Health and industry-sponsored clinical studies. He is the coordinating PI for investigator-initiated and pharmaceutical sponsored clinical trials in scleroderma that led to the regulatory approval of tocilizumab in scleroderma- associated interstitial lung disease. His current research focus on developing, validating, and refining outcome measures in rheumatic diseases and designing controlled trials. He is lead author of the scleroderma composite index (called ACR CRISS and Revised CRISS) that is undergoing regulatory review as an approvable endpoint. He received the prestigious 2015 Henry Kunkel Young Investigator Award from the American College of Rheumatology and was inducted in the 2023 American Society for Clinical Investigation.</p>

収録刊行物

  • 西日本皮膚科

    西日本皮膚科 85 (4), 315-316, 2023-08-01

    日本皮膚科学会西部支部

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ